A SEON survey of 2,026 U.S. adults reveals that while 68% use AI agents weekly for personal tasks, half are uncomfortable letting AI handle credit card purchases. Only 15% would share financial info with AI, and 43% lack confidence in spotting fraudulent AI requests. Most consumers (65%) hold AI companies responsible for fraud committed by their agents. The findings highlight a trust gap as AI agents become more involved in sensitive financial activities, urging businesses to improve fraud detection and customer support to build trust.
U.S. consumers' trust in AI agents is mixed, with 65% blaming AI companies for fraud by their agents. For readers following the Technology sector, here is Pluang's market snapshot as of Nov 02, 2026 19:21 WIB: out of 150 priced US tech stocks, 96 rose and 40 fell. Notable movers include STM at USD 48.15 (+3.02%, typical hold time 66 days), AXTI at USD 56.68 (+2.93%, 18 days), and CRDO at USD 155.00 (+2.66%, 25 days).
Callan JMB has received and will install a QuickStrip™ oral thin-film production line from Rapid Dose Therapeutics at its Texas facility, marking a key step in expanding its domestic pharmaceutical manufacturing. This new capability aims to produce f...
Known, a company developing accountability infrastructure for autonomous AI, announced that Edna Conway, former senior security executive at Microsoft and Cisco, has joined its Advisory Council. Conway brings extensive experience in cybersecurity and...
Radiopharm Theranostics announced progress in its oncology radiopharmaceutical pipeline, including preparing for a pivotal Phase 3 imaging trial of RAD101 for recurrent brain metastases after a successful FDA End-of-Phase 2 meeting. The company also ...
UroGen Pharma has dosed the first patient in a Phase 1 trial testing UGN-501, a next-generation oncolytic virus for non-muscle invasive bladder cancer (NMIBC). The trial aims to evaluate the safety and tolerability of UGN-501 administered directly in...
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Tigo Energy, Fluence Energy, and Anavex Life Sciences. The lawsuits allege these companies made false or misleading stat...
